Clinical Trials Directory

Trials / Completed

CompletedNCT05986123

Safety and Efficacy of Topical Cream for Post-inflammatory Hyperpigmentation Skin Among Malaysians

Safety and Efficacy of Topical Cream Containing Natural Plant Extracts, Niacinamide, and Arbutin for Post-inflammatory Hyperpigmentation Skin Among Malaysians

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
USMARI Research & Innovation Centre · Industry
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

This study was conducted to determine safety and efficacy of topically applied cream containing combination of niacinamide, arbutin, Scutellaria Baicalensis Root Extract, Centella Asiatica Extract and Camellia Sinensis Leaf Extract for its skin brightening effect on post-inflammatory hyperpigmentation among the Malaysian population. The study duration is 20 weeks and the skin assessment will be carried out at baseline, week 4, week 8, week 12, week 16 and week 20.The main questions this study aims to answer are: 1. To determine the efficacy of topical cream containing natural plant extracts, niacinamide, and arbutin for post-inflammatory hyperpigmentation among Malaysians. 2. To investigate the safety of topical cream containing natural plant extracts, niacinamide, and arbutin for post-inflammatory hyperpigmentation among Malaysians. 3. To assess the participants satisfaction of using topical cream containing natural plant extracts, niacinamide, and arbutin for post-inflammatory hyperpigmentation among Malaysians.

Conditions

Interventions

TypeNameDescription
OTHERTopical cream Z for PIHThe topical cream Z contain combination of niacinamide, arbutin, Scutellaria Baicalensis Root Extract, Centella Asiatica Extract and Camellia Sinensis Leaf Extract. Participants will used the topical cream twice daily for 20 weeks

Timeline

Start date
2023-11-01
Primary completion
2025-12-30
Completion
2026-01-30
First posted
2023-08-14
Last updated
2026-03-06

Locations

1 site across 1 country: Malaysia

Source: ClinicalTrials.gov record NCT05986123. Inclusion in this directory is not an endorsement.

Safety and Efficacy of Topical Cream for Post-inflammatory Hyperpigmentation Skin Among Malaysians (NCT05986123) · Clinical Trials Directory